rs9722
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006272.3(S100B):c.*37C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.131 in 1,598,392 control chromosomes in the GnomAD database, including 19,105 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.21 ( 4636 hom., cov: 33)
Exomes 𝑓: 0.12 ( 14469 hom. )
Consequence
S100B
NM_006272.3 3_prime_UTR
NM_006272.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.84
Publications
53 publications found
Genes affected
S100B (HGNC:10500): (S100 calcium binding protein B) The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21; however, this gene is located at 21q22.3. This protein may function in Neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis and axonal proliferation, and inhibition of microtubule assembly. Chromosomal rearrangements and altered expression of this gene have been implicated in several neurological, neoplastic, and other types of diseases, including Alzheimer's disease, Down's syndrome, epilepsy, amyotrophic lateral sclerosis, melanoma, and type I diabetes. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| S100B | NM_006272.3 | c.*37C>T | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000291700.9 | NP_006263.1 | ||
| S100B | XM_017028424.3 | c.*37C>T | 3_prime_UTR_variant | Exon 3 of 3 | XP_016883913.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| S100B | ENST00000291700.9 | c.*37C>T | 3_prime_UTR_variant | Exon 3 of 3 | 1 | NM_006272.3 | ENSP00000291700.4 | |||
| S100B | ENST00000367071.4 | c.*125C>T | 3_prime_UTR_variant | Exon 4 of 4 | 1 | ENSP00000356038.4 | ||||
| S100B | ENST00000397648.1 | c.*37C>T | 3_prime_UTR_variant | Exon 2 of 2 | 1 | ENSP00000380769.1 |
Frequencies
GnomAD3 genomes AF: 0.207 AC: 31442AN: 152026Hom.: 4615 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
31442
AN:
152026
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.157 AC: 38687AN: 246542 AF XY: 0.154 show subpopulations
GnomAD2 exomes
AF:
AC:
38687
AN:
246542
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.123 AC: 177377AN: 1446248Hom.: 14469 Cov.: 29 AF XY: 0.124 AC XY: 89309AN XY: 719628 show subpopulations
GnomAD4 exome
AF:
AC:
177377
AN:
1446248
Hom.:
Cov.:
29
AF XY:
AC XY:
89309
AN XY:
719628
show subpopulations
African (AFR)
AF:
AC:
13881
AN:
32656
American (AMR)
AF:
AC:
4010
AN:
43006
Ashkenazi Jewish (ASJ)
AF:
AC:
3568
AN:
25922
East Asian (EAS)
AF:
AC:
13835
AN:
39590
South Asian (SAS)
AF:
AC:
16146
AN:
84640
European-Finnish (FIN)
AF:
AC:
6970
AN:
53314
Middle Eastern (MID)
AF:
AC:
890
AN:
5702
European-Non Finnish (NFE)
AF:
AC:
109065
AN:
1101616
Other (OTH)
AF:
AC:
9012
AN:
59802
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
6619
13238
19858
26477
33096
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4220
8440
12660
16880
21100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.207 AC: 31514AN: 152144Hom.: 4636 Cov.: 33 AF XY: 0.208 AC XY: 15460AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
31514
AN:
152144
Hom.:
Cov.:
33
AF XY:
AC XY:
15460
AN XY:
74382
show subpopulations
African (AFR)
AF:
AC:
16854
AN:
41486
American (AMR)
AF:
AC:
2168
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
478
AN:
3466
East Asian (EAS)
AF:
AC:
1760
AN:
5170
South Asian (SAS)
AF:
AC:
1045
AN:
4822
European-Finnish (FIN)
AF:
AC:
1431
AN:
10592
Middle Eastern (MID)
AF:
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7111
AN:
68000
Other (OTH)
AF:
AC:
442
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1160
2319
3479
4638
5798
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
314
628
942
1256
1570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1042
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.